In the Press

Weekly Ketamine Infusions Show Initial, Repeated Depression Benefits

A new study shows that weekly ketamine infusions are associated with continued and maintained reductions in depressive symptoms among patients with treatment-resistant depression. The findings, which are considered novel among studies assessing ketamine administration for patients with treatment-resistant depression, evidence the promising role the controversial drug could play in psychiatric care. A team of investigators, led […]

0 comments

The FDA accepted a brand new ketamine melancholy drug — right here’s what’s subsequent

For years, ketamine clinics across the country have offered intravenous infusions as a fast-acting treatment for severe depression. But last week, the US Food and Drug Administration approved a version of ketamine, called esketamine, to do the same thing — so what’s the difference and what will this mean for newly interested patients? Ketamine, sometimes […]

0 comments

The FDA approved a new ketamine depression drug — here’s what’s next

The newly approved drug, esketamine, is one half of the ketamine compound. By Angela Chen@chengela  Mar 11, 2019, 3:45pm EDTIllustration by Alex Castro/The Verge For years, ketamine clinics across the country have offered intravenous infusions as a fast-acting treatment for severe depression. But last week, the US Food and Drug Administration approved a version of ketamine, called esketamine, […]

3 Comments

FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

For Immediate Release March 5, 2019 Release The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk of serious adverse outcomes resulting […]

8 Comments

Johnson & Johnson’s nasal spray for depression wins FDA panel backing

(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Tuesday voted in favor of Johnson & Johnson’s experimental nasal spray, which has a compound similar to often-abused ketamine, bringing the drug closer to approval. The panel voted 14-2 in favor of the drug esketamine, developed to treat major depression in patients […]

3 Comments

Ketamine Could Be the Key to Reversing America’s Rising Suicide Rate

A version of the club drug is expected to be approved for depression in March. Researchers think it could help treat suicidal thinking. Joe Wright has no doubt that ketamine saved his life. A 34-year-old high school teacher who writes poetry every day on a typewriter, Wright was plagued by suicidal impulses for years. The […]

0 comments

Can We Stop Suicides?

By Moises Velasquez-Manoff –Contributing Opinion Writer It’s been way too long since there was a new class of drugs to treat depression. Ketamine might be the solution. In May of 2017, Louise decided that her life was just too difficult, so she’d end it. In the previous four years, three siblings and a half-sibling had died, […]

0 comments

Can a party drug stop the increasing rate of suicide?

Ketamine is showing promise in alleviating suicidal thoughts. DEREK BERES 03 December, 2018 The popular party drug has shown promise in stopping suicidal thoughts in a number of small clinical studies. First synthesized in 1962, the anesthetic was used to treat Vietnam War soldiers in the early seventies. Though the accompanying hallucinations are a roadblock to […]

0 comments

Trippy depression treatment? Hopes and hype for ketamine

By Lindsey Tanner | APOctober 31 at 12:14 PM CHICAGO — It was launched decades ago as an anesthetic for animals and people, became a potent battlefield pain reliever in Vietnam and morphed into the trippy club drug Special K. Now the chameleon drug ketamine is finding new life as an unapproved treatment for depression and suicidal behavior. […]

0 comments